ctrl K

Price Alert

Corvus Pharmaceuticals In... (CRVS)

NASDAQ: CRVS · Real-Time Price · USD

5.42

0.57 (11.75%)

At close: Aug 15, 2025, 3:59 PM

5.43

0.28%

After-hours: Aug 15, 2025, 07:49 PM EDT

Corvus Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.74M	12.62M	13.16M	63.46M
Short-Term Investments	43.22M	14.53M	29.14M	5.99M
Long-Term Investments	12.54M	16.12M	21.88M	34.27M
Other Long-Term Assets	632K	89K	1.84M	2.55M
Receivables	216K	63K	633K	539K
Inventory	n/a	n/a	-735K	-667K
Other Current Assets	548K	220K	837K	795K
Total Current Assets	54.41M	27.96M	43.66M	71.31M
Property-Plant & Equipment	1.33M	1.39M	2.22M	3.19M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.5M	17.6M	25.94M	40M
Total Assets	68.91M	45.55M	68.24M	109.45M
Account Payables	2.58M	1.52M	1.98M	1.56M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	185K	1.37M	1.23M	1.05M
Other Current Liabilities	29.83M	1.91M	43K	921K
Total Current Liabilities	35.4M	6.87M	10.75M	9.69M
Long-Term Debt	n/a	n/a	1.37M	2.6M
Other Long-Term Liabilities	n/a	n/a	-1.37M	-2.6M
Total Long-Term Liabilities	937K	n/a	1.37M	2.6M
Total Liabilities	36.34M	6.87M	12.13M	12.29M
Total Debt	1.12M	1.37M	2.6M	3.65M
Common Stock	7K	5K	5K	5K
Retained Earnings	-397.01M	-334.72M	-307.69M	-266.38M
Comprehensive Income	-1.29M	-967K	-563K	1.87M
Shareholders Equity	32.57M	38.68M	56.12M	97.16M
Total Investments	55.76M	30.65M	51.02M	40.26M